Peter Kellman

Radiology, Nuclear Medicine and Imaging · 2001–2017

A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

Whom Peter Kellman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Michael W. Marcellin

Who trusts Peter Kellman overall

  1. Michael S. Hansen
  2. Mehmet Akçakaya
  3. A. Deshmane
  4. Sajan Goud Lingala
  5. Martin Uecker
  6. Steen Moeller
  7. Stamatios N. Sotiropoulos
  8. Li Feng
  9. Thomas Sangild Sørensen
  10. Vikas Gulani

Papers from Peter Kellman's perspective

Ordered by how strongly the researchers Peter Kellman trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. (New England Journal of Medicine)
  2. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. (Journal of the American College of Cardiology)
  3. Optimization and validation of a fully‐integrated pulse sequence for modified look‐locker inversion‐recovery (MOLLI) T1 mapping of the heart (Journal of Magnetic Resonance Imaging)
  4. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold (Journal of Cardiovascular Magnetic Resonance)
  5. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. (European Heart Journal)
  6. An improved MR imaging technique for the visualization of myocardial infarction. (Radiology)
  7. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. (JACC Cardiovascular Imaging)
  8. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. (Journal of the American Medical Association (JAMA))
  9. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (Circulation)
  10. Mechanisms of fibrosis: therapeutic translation for fibrotic disease (Nature Medicine)

Their papers